Gregory L. Barnett
Treasurer bei BioSphere Medical, Inc.
Aktive Positionen von Gregory L. Barnett
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
BioSphere Medical, Inc.
BioSphere Medical, Inc. Medical SpecialtiesHealth Technology BioSphere Medical, Inc. develops, manufactures and markets microsphere technology to medical applications. The company uses microsphere technology to develop its products for medical applications using embolotherapy techniques. It offers Embosphere Microspheres for uterine fibroids, hypervascularized tumors and other arteriovenous malformations, EmboGold Microspheres for Hypervascularized tumors and arteriovenous malformations, EmboCath Infusion Catheter and Segway Guidewire for peripheral embolization procedures and HepaSphere Microspheres for liver cancer. The company was founded in 1993 and is headquartered in Rockland, MA. | Treasurer | 14.09.2010 | - |
Karriereverlauf von Gregory L. Barnett
Ehemalige bekannte Positionen von Gregory L. Barnett
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
MERIT MEDICAL SYSTEMS, INC. | Comptroller/Controller/Auditor | 01.06.1990 | 04.11.2015 |
Ausbildung von Gregory L. Barnett
University of Utah | Undergraduate Degree |
Statistik
International
Vereinigte Staaten | 4 |
Operativ
Comptroller/Controller/Auditor | 1 |
Treasurer | 1 |
Undergraduate Degree | 1 |
Sektoral
Health Technology | 3 |
Consumer Services | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
Börsennotierte Unternehmen | 1 |
---|---|
MERIT MEDICAL SYSTEMS, INC. | Health Technology |
Private Unternehmen | 1 |
---|---|
BioSphere Medical, Inc.
BioSphere Medical, Inc. Medical SpecialtiesHealth Technology BioSphere Medical, Inc. develops, manufactures and markets microsphere technology to medical applications. The company uses microsphere technology to develop its products for medical applications using embolotherapy techniques. It offers Embosphere Microspheres for uterine fibroids, hypervascularized tumors and other arteriovenous malformations, EmboGold Microspheres for Hypervascularized tumors and arteriovenous malformations, EmboCath Infusion Catheter and Segway Guidewire for peripheral embolization procedures and HepaSphere Microspheres for liver cancer. The company was founded in 1993 and is headquartered in Rockland, MA. | Health Technology |
- Börse
- Insiders
- Gregory L. Barnett
- Erfahrung